跳至主要内容
临床试验/JPRN-UMIN000020163
JPRN-UMIN000020163已完成未知

Burden of illness and epidemiology of patients with severe asthma in Japan - Japanese EPI/BOI Study in Severe Asthma

Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University0 个研究点目标入组 250 人开始时间: 2015年12月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. No treatment record of asthma as defined by ICD-10 codes (J45) in any of the following periods in order to secure two-years observation during the Baseline and Follow-up period. Given the prescription days at one visit is 120 days, at least one record of asthma will be required within 5 months of pre-baseline, and 5 months of after follow-up period, respectively. 5 months before Baseline period Follow-up period 5 months after Follow-up period 2. A diagnosis for cystic fibrosis. 3. A diagnosis for any cancer of respiratory system. 4. Any autoimmune diagnoses identified. 5. A diagnosis for a malignant disease under the treatment at the timing of measurement of blood eosinophil counts.

研究者

发起方
Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University

相似试验